Title:
Scientists Unveil a Promising New Strategy For Combating Pancreatic Cancer: Common mutation in pancreatic cancer creates a sensitivity to some PARP1 inhibitor drugs
Published:
Penn Medicine News (Press Release), University of Pennsylvania, 14 December 2020
From the article:
A DNA mutation that occurs frequently in the development of many pancreatic tumors appears to make these cancers vulnerable to an existing type of drug known as PARP inhibitors, according to a new study from scientists in the Perelman School of Medicine at the University of Pennsylvania.